Bridge Biotherapeutics (Korea) Buy Hold or Sell Recommendation
| 288330 Stock | KRW 3,940 120.00 2.96% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding Bridge Biotherapeutics is 'Cautious Hold'. Macroaxis provides Bridge Biotherapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 288330 positions.
Check out Bridge Biotherapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Bridge and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Bridge Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Bridge |
Execute Bridge Biotherapeutics Buy or Sell Advice
The Bridge recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bridge Biotherapeutics. Macroaxis does not own or have any residual interests in Bridge Biotherapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bridge Biotherapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Bridge Biotherapeutics Trading Alerts and Improvement Suggestions
| Bridge Biotherapeutics had very high historical volatility over the last 90 days | |
| The company reported the revenue of 1.92 B. Net Loss for the year was (26.28 B) with loss before overhead, payroll, taxes, and interest of (1.12 B). | |
| Bridge Biotherapeutics has accumulated about 8.2 B in cash with (21.13 B) of positive cash flow from operations. | |
| Roughly 30.0% of the company shares are owned by insiders or employees |
Bridge Biotherapeutics Returns Distribution Density
The distribution of Bridge Biotherapeutics' historical returns is an attempt to chart the uncertainty of Bridge Biotherapeutics' future price movements. The chart of the probability distribution of Bridge Biotherapeutics daily returns describes the distribution of returns around its average expected value. We use Bridge Biotherapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bridge Biotherapeutics returns is essential to provide solid investment advice for Bridge Biotherapeutics.
| Mean Return | 0.26 | Value At Risk | -9.94 | Potential Upside | 14.21 | Standard Deviation | 7.92 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bridge Biotherapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Bridge Biotherapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bridge Biotherapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bridge Biotherapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bridge stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.26 | |
β | Beta against Dow Jones | -0.7 | |
σ | Overall volatility | 8.13 | |
Ir | Information ratio | 0.03 |
Bridge Biotherapeutics Volatility Alert
Bridge Biotherapeutics is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bridge Biotherapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bridge Biotherapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Bridge Biotherapeutics Fundamentals Vs Peers
Comparing Bridge Biotherapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bridge Biotherapeutics' direct or indirect competition across all of the common fundamentals between Bridge Biotherapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bridge Biotherapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bridge Biotherapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Bridge Biotherapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Bridge Biotherapeutics to competition |
| Fundamentals | Bridge Biotherapeutics | Peer Average |
| Return On Equity | -75.4 | -0.31 |
| Current Valuation | 29.26 B | 16.62 B |
| Shares Owned By Insiders | 30.27 % | 10.09 % |
| Shares Owned By Institutions | 9.09 % | 39.21 % |
| Revenue | 1.92 B | 9.43 B |
| Gross Profit | (1.12 B) | 27.38 B |
| EBITDA | (21.27 B) | 3.9 B |
| Net Income | (26.28 B) | 570.98 M |
| Cash And Equivalents | 8.2 B | 2.7 B |
| Total Debt | 53.63 M | 5.32 B |
| Current Ratio | 1.05 X | 2.16 X |
| Cash Flow From Operations | (21.13 B) | 971.22 M |
| Number Of Employees | 4 | 18.84 K |
| Market Capitalization | 217.07 B | 19.03 B |
| Total Asset | 46.66 B | 29.47 B |
| Net Asset | 46.66 B |
Bridge Biotherapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Bridge . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.1 | |||
| Daily Balance Of Power | (0.28) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 3935.0 | |||
| Day Typical Price | 3936.67 | |||
| Market Facilitation Index | 430.0 | |||
| Price Action Indicator | (55.00) | |||
| Period Momentum Indicator | (120.00) | |||
| Relative Strength Index | 64.64 |
About Bridge Biotherapeutics Buy or Sell Advice
When is the right time to buy or sell Bridge Biotherapeutics? Buying financial instruments such as Bridge Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Bridge Biotherapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials ETFs Thematic Idea Now
Financials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Bridge Stock
Bridge Biotherapeutics financial ratios help investors to determine whether Bridge Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bridge with respect to the benefits of owning Bridge Biotherapeutics security.